Exclusive

Publication

Byline

US Patent Issued to PHARMA CINQ on June 9 for "Imidazoquinoline compound having anti-inflammatory, antifugal, antiparasitic, and anticancer activity" (Maryland Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,739, issued on June 9, was assigned to PHARMA CINQ LLC (Rockville, Md.). "Imidazoquinoline compound having anti-inflammatory, antifugal, ant... Read More


US Patent Issued to BIOINTERVENE on June 9 for "Adenosine analogs for the treatment of disease" (California, Florida, Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,740, issued on June 9, was assigned to BIOINTERVENE INC. (Atherton, Calif.). "Adenosine analogs for the treatment of disease" was invented b... Read More


US Patent Issued to Neurocrine Biosciences on June 9 for "Substituted pyrido[2,1-aisoquinolines as VMAT2 inhibitors" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,741, issued on June 9, was assigned to Neurocrine Biosciences Inc. (San Diego). "Substituted pyrido[2,1-aisoquinolines as VMAT2 inhibitors" ... Read More


US Patent Issued to NFLECTION THERAPEUTICS on June 9 for "Crystalline forms of a pyrrolopyridine-aniline compound" (Indiana, Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,742, issued on June 9, was assigned to NFLECTION THERAPEUTICS INC. (Boston). "Crystalline forms of a pyrrolopyridine-aniline compound" was i... Read More


US Patent Issued to XIZANG HAISCO PHARMACEUTICAL on June 9 for "Tricyclic fused heterocyclic PDE3/4 dual inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,743, issued on June 9, was assigned to XIZANG HAISCO PHARMACEUTICAL Co. LTD. (Lhoka, China). "Tricyclic fused heterocyclic PDE3/4 dual inhib... Read More


US Patent Issued to Pathios Therapeutics on June 9 for "N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[cpyridine-10-carboxamide derivatives and similar compounds as GPR65 modulators for the treatment of cancer" (British Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,744, issued on June 9, was assigned to Pathios Therapeutics Ltd. (Milton, Great Britain). "N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epimin... Read More


US Patent Issued to Hoffmann-La Roche on June 9 for "Amino-pyrimidine cyclo-amides" (French, German, Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,745, issued on June 9, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Amino-pyrimidine cyclo-amides" was invented by Angelica... Read More


US Patent Issued to NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY on June 9 for "Ketorolaco derivative, pharmaceutical composition and preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,746, issued on June 9, was assigned to NANJING HERON PHARMACEUTICAL SCIENCE AND TECHNOLOGY Co. LTD. (Nanjing, China). "Ketorolaco derivative... Read More


US Patent Issued to OCUMENSION THERAPEUTICS (SUZHOU) on June 9 for "Salt form and crystal form of pyrazole substituted imidazo[1,2-aquinoxaline derivative" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,747, issued on June 9, was assigned to OCUMENSION THERAPEUTICS (SUZHOU) Co. LTD (Suzhou City, China). "Salt form and crystal form of pyrazol... Read More


US Patent Issued to JIANGSU TASLY DIYI PHARMACEUTICAL on June 9 for "Wee1 inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,748, issued on June 9, was assigned to JIANGSU TASLY DIYI PHARMACEUTICAL Co. LTD. (Jiangsu, China). "Wee1 inhibitor and use thereof" was inv... Read More